Decreased Outpatient Fluoroquinolone Prescribing Using A Multimodal Antimicrobial Stewardship Initiative
22 May 2020
Fluoroquinolones are prescribed antibiotics in the outpatient setting though they have serious side effects. This study evaluates the impact of stewardship interventions on total and inappropriate prescribing of fluoroquinolones in outpatient settings in a large county hospital and health system.
A multimodal stewardship initiative appears to effectively reduce both total and inappropriate outpatient fluoroquinolone prescriptions.
Further reading: Open Forum Infectious Diseases
Author(s): Kevin Lin, PharmD, Yorgo Zahlanie, MD, Jessica K Ortwine, PharmD, BCIDP, Norman S Mang, PharmD, BCIDP, Wenjing Wei, PharmD, BCPS-AQ ID, L Steven Brown, MS, CPH, Bonnie C Prokesch, MD
Healthy Patients
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
